• DarioHealth won a contract from a Fortune 50 employer to provide its digital cardiometabolic care platform for diabetes or hypertension.
• Program targets more than 100,000 eligible employees; launch expected in fall 2026.
• Annual recurring revenue expected to start by end-2026; contribution expected to ramp through 2027.
• Deal marks DarioHealth’s fifth Fortune 50 client.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607160730PR_NEWS_USPR_____LN05362) on July 16, 2026, and is solely responsible for the information contained therein.